Palmetto Infusion is an ambulatory infusion company with a focus on in-home care that aims to provide unique and life-altering treatments for autoimmune diseases. Founded in 1999, the company believes in offering hope to patients by enabling them to achieve wellness and a real quality of life despite challenging health diagnoses. With a core philosophy of operating with empathy and servant leadership, Palmetto Infusion has built a dedicated team committed to personal ownership over patient health. The company operates in Health Care industry and is based in the United States. The latest investment for Palmetto Infusion was a Private Equity Round investment on 16 April 2019, led by Carousel Capital. Currently, the company has expanded to 35+ clinic locations across six states in the Southeast and continues to grow, welcoming others to join their extended family.
No recent news or press coverage available for Palmetto Infusion.